Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease

[1]  F. Calon,et al.  High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model , 2010, Neurobiology of Aging.

[2]  Dietmar Rudolf Thal,et al.  Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances , 2009, Neurobiology of Aging.

[3]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[4]  H. Tanila,et al.  Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD) , 2007, Neurobiology of Disease.

[5]  Brian J. Bacskai,et al.  Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease , 2006, Neurobiology of Disease.

[6]  E. Golob,et al.  Vascular volume and blood‐brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls , 2006, Journal of magnetic resonance imaging : JMRI.

[7]  P. Zandi,et al.  Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. , 2006, Archives of neurology.

[8]  P. Hof,et al.  Stereologic Analysis of Microvascular Morphology in the Elderly: Alzheimer Disease Pathology and Cognitive Status , 2006, Journal of neuropathology and experimental neurology.

[9]  Mathias Jucker,et al.  Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .

[10]  X. Tong,et al.  Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  C. Anthony Hunt,et al.  Glucose transport to the brain: A systems model , 2005, Brain Research Reviews.

[12]  D. Ingram,et al.  Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease , 2005, Brain Research Bulletin.

[13]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.

[14]  K. Jellinger,et al.  Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease , 2005, Journal of the Neurological Sciences.

[15]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[16]  E. Masliah,et al.  Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer’s disease with the neurotrophic compound Cerebrolysin™ , 2005, Journal of Neural Transmission.

[17]  N. Patel,et al.  Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis , 2004, Neuroscience Letters.

[18]  R. Castellani,et al.  Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis , 2004, Neurobiology of Aging.

[19]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[20]  G. Small,et al.  The Role of Positron Emission Tomography in the Diagnosis of Alzheimer's Disease , 2004, Journal of the American Geriatrics Society.

[21]  Fiona Crawford,et al.  Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice , 2004, Brain Research.

[22]  D. Dickstein,et al.  Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .

[23]  Thomas Krucker,et al.  Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease , 2003, The Journal of Neuroscience.

[24]  F. Crawford,et al.  Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. , 2003, Neurological research.

[25]  J. Temsamani,et al.  Evidence for an active transport of morphine‐6‐β‐d‐glucuronide but not P‐glycoprotein‐mediated at the blood–brain barrier , 2003, Journal of neurochemistry.

[26]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[27]  Markus Rudin,et al.  Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[28]  B J Shepstone,et al.  Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. , 2002, Brain : a journal of neurology.

[29]  C. Iadecola,et al.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.

[30]  R. Kalaria.  Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations , 2002, Cerebrovascular Diseases.

[31]  George A. Carlson,et al.  Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.

[32]  Christophe Rousselle,et al.  Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  H. Chui,et al.  Vascular Basement Membrane Pathology and Alzheimer's Disease , 1997, Annals of the New York Academy of Sciences.

[34]  R. Kalaria,et al.  Increased collagen content of cerebral microvessels in Alzheimer's disease , 1995, Brain Research.

[35]  P. R. Hof,et al.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders , 1994, Acta Neuropathologica.

[36]  W. Scholz.  Studien zur Pathologie der Hirngefäße II , 1938 .

[37]  R. Egleton,et al.  Pathophysiology of the blood-brain barrier: animal models and methods. , 2008, Current topics in developmental biology.

[38]  D. Bennett,et al.  Biochemical Characterization of Aβ and Tau Pathologies in Mild Cognitive Impairment and Alzheimer's Disease , 2007 .

[39]  F. LaFerla,et al.  Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice , 2005, Journal of Neuroinflammation.

[40]  P. Bornstein,et al.  Structurally distinct collagen types. , 1980, Annual review of biochemistry.

[41]  Justin Paul,et al.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease , 2007, The Journal of experimental medicine.